NCT00430027: Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma |
|
|
| Terminated | N/A | 8 | US | Capecitabine, Xeloda, Oxaliplatin, Eloxatin, Cetuximab, Erbitux | University of Colorado, Denver, Bristol-Myers Squibb, Sanofi | Esophageal Adenocarcinoma | 08/08 | 08/08 | | |